Coinheritance of hereditary spherocytosis and reversibility of cirrhosis in a young female patient with hereditary hemochromatosis

European Journal of Medical Research

Volumn 14, Issue 4, 2009, Pages 182-184

  Höblinger, Aksana ^a   Erdmann, C ^a   Strassburg, C P ^b   Sauerbruch, T ^a   Lammert, F ^a,c  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c SAARLAND UNIVERSITY   (Germany)

Author keywords

Hereditary hemochromatosis; Hereditary spherocytosis; Iron overload; Liver cirrhosis

Indexed keywords

FERRITIN; HFE PROTEIN; IRON;

ABNORMAL LABORATORY RESULT; ADULT; ARTICLE; BLOOD ANALYSIS; CASE REPORT; ECHOGRAPHY; ELASTOGRAPHY; FEMALE; FERRITIN BLOOD LEVEL; GENE MUTATION; HEMOCHROMATOSIS; HEMOLYTIC ANEMIA; HEPATOSPLENOMEGALY; HEREDITARY SPHEROCYTOSIS; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; INHERITANCE; IRON BLOOD LEVEL; IRON OVERLOAD; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER HEMOSIDEROSIS; MUTATIONAL ANALYSIS; PHLEBOTOMY; VIRUS INFECTION;

EID: 65449159067     PISSN: 09492321     EISSN: None     Source Type: Journal    
DOI: 10.1186/2047-783x-14-4-182     Document Type: Article

References (33)

1. Eber SW, Pekrun A, NeufeJdt A, Schröter W. Prevalence of increased osmotic fragility of erythrocytes in German blood donors: screening using a modified glycerol lysis test. Ann Hematol. 1992 Feb; 64(2):88-92.
2. Delaunay J. Molecular basis of red cell membrane disorders. Acta Haematol. 2002; 108(4):210-8.
3. Bolton-Maggs PH, Stevens RF, Dodd NJ, Lamont G, Tittensor P, King MJ; General Haematology Task Force of the British Committee for Standards in Haematology. Guidelines for the diagnosis and management of hereditary spherocytosis. Br J Haematol. 2004 Aug; 126(4):455-74.
4. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, Dormishian F, Domingo R, Ellis MC, Fullan A, Hinton LM, Jones NL, Kimmel BE, Kronmal GS, Lauer P, Lee VK, Loeb DB, Mapa FA, McClelland E, Meyer NC, Mintier GA, Moeller N, Moore T, Morikang E, Prass CE, Quintana L, Starnes SM, Schatzman RC, Brunke KJ, Drayna DT, Risch NJ, Bacon BR, Wolff RK. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996 Aug; 13(4): 399-408.
5. Edwards CQ, Griffen LM, Goldgar D, Drummond C, Skolnick MH, Kushner JP. Prevalence of hemochromatosis among 11,065 presumably healthy blood donors. N Eng J Med. 1998 May 26; 318(21):1355-62.
6. Lawrence RD. Haemochromatosis in three families and in a woman. Lancet 1949 Apr 30; 1(18): 736.
7. Barry M, Scheurer PJ, Scherlock S, Ross CF, Williams R. Hereditary spherocytosis with secondary hemochromatosis. Lancet 1968 Aug 31; 2(7566): 481-5.
8. Brandenberg JB, Demarmels Biasiutti F, Lutz HU, Wuillemin WA. Hereditary spherocytosis and hemochromatosis. Ann Hematol 2002 Apr; 81(4): 202-9.
9. Ichiche M, Lacor P, Hoorens A, Brande JV, Brussaard H, Vanstraelen D. Congenital spherocytosis with hereditary hemochromatosis without pathogenic mutations in the HFE gene. Eur J Intern Med 2004 Nov; 15(7): 460-2.
10. Fargion S, Cappellini MD, Piperno A, Panajotopoulos N, Ronchi G, Fiorelli G. Association of hereditary spherocytosis and idiopathic hemochromatosis. A synergistic effect in determining iron overload. Am J Clin Pathol 1986 Nov; 86(5): 645-9.
11. Lopez DE, Kohan M, Ferreno D, Raffa MP, Prytyka A. Hemochromatosis associated with hereditary spherocytosis. Acta Gastroenterol Lationoam 1997; 27(4): 267-70.
12. Mohler DN, Wheby MS. Case report: hemochromatosis heterozygotes may have significant iron overload when they also have hereditary spherocytosis. Am J Med Sci 1986 Nov; 292(5): 320-4.
13. Montes-Cano MA, Rodríguez-Muñoz F, Franco-Osorio R, Núñez-Roldán A, González-Escribano MF. Hereditary spherocytosis associated with mutations in HFE gene. Ann Hematol 2003 Dec; 82(12): 769-72.
14. O'Mahony S, O'Brien PA, Whelton MJ. Genetic hemochromatosis and congenital spherocytosis. Lancet 1987 Jan 31; 1(8527): 282.
15. Takegoshi T, Nishino T, Tanino M, Nonokura A, Otha G. An autopsy case of hemochromatosis and hepatoma combined with hereditary spherocytosis. Jpn J Med 1984 Feb; 23(1): 48-52.
16. Wilson JD, Scott PJ, North JDK. Hemochromatosis in association with hereditary spherocytosis. Arch Intern Med. 1967 Dec; 120(6): 701-7.
17. Zimelman AP, Miller A. Primary hemochromatosis with hereditary spherocytosis. Arch Intern Med. 1980 Jul; 140(7): 983-4.
18. Fraquelli M, Rigamonti C, Casazza G, Conte D, Donato MF, Ronchi G, Colombo M. Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease. Gut. 2007 Jul; 56(7):968-73.
19. Cobbold JF, Morin S, Taylor-Robinson SD. Transient elastography for the assessment of chronic liver disease: ready for the clinic? World J Gastroentrol. 2007 Sep 28; 13(36):4791-7.
20. Foucher J, Chanteloup E, Vergniol J, Castéra L, Le Bail B, Adhoute X, Bertet J, Couzigou P, de Lédinghen V. Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut. 2006 Mar; 55(3):403-8.
21. Talwalkar JA, Kurtz DM, Schoenleber SJ, West CP, Montori VM. Ultrasound-based transient elastography for the detection of hepatic fibrosis: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2007 Oct; 5(10):1214-20.
22. Pietrangelo A. Molecular insights into the pathogenesis of hereditary haemochromatosis. Gut. 2006 Apr; 55(4):564-8.
23. De Domenico I, Ward DM, Kaplan J. Hepcidin regulation: ironing out the details. J Clin Invest. 2007 Jul; 117(7):1755-8.
24. Ganz T. Hepcidin and its role in regulating systemic iron metabolism. Hematology Am Soc Hematol Educ Program. 2006;29-35, 507. Review.
25. Papanikolaou G, Tzillianos M, Christakis JI, Bogdanos D, Tsimirika K, MacFarlane J, Goldberg JP, Sakellaroopoulos N, Ganz T, Nemeth E. Hepcidin in iron overload disorders. Blood 2005 May 15; 105(10):4103-5.
26. Bridle KR, Frazer DM, Wilkins SJ, Dixon JL, Purdie DM, Crawford DH, Subramaniam VN, Powell LW, Anderson GJ, Ramm GA. Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis. Lancet 2003 Feb 22; 361(9358):669-73.
27. Nicolas G, Viatte L, Lou DQ, Bennoun M, Beaumont C, Kahn A, Andrews NC, Vaulont S. Constitutive hepcidin expression prevents iron overload in a mouse model of hemochromatosis. Nat Genet 2003 May; 34(1):97-101.
28. Viatte L, Nicolas G, Lou DQ, Bennoun M, Lesbordes-Brion JC, Canonne-Hergaux F, Schönig K, Bujard H, Kahn A, Andrews NC, Vaulont S. Chronic hepcidin induction causes hyposideremia and alters the pattern of cellular iron accumulation in hemochromatotic mice. Blood 2006 Apr 1; 107(7): 2952-8.
29. Cappellini MD, Fargion S, Sampietro M, Graziadei G, Fiorelli G. Nontransfusional iron overload thalassemia intermedia: role of the hemochromatosis allele (letter). Blood 1998 Dec 1; 92(11): 4479-80.
30. Conrad ME. Sickle cell disease and hemochromatosis. Am J Hematol 1991 Oct; 38(2): 150-2.
31. Hitchins R, Naughton L, Kerlin P, Cobbcroft R. Spur cell anemia (acanthocytosis) complicating idiopathic hemochromatosis. Pathology 1988 Jan; 20(1): 59-61.
32. Friedman SL. Reversibility of hepatic fibrosis and cirrhosis - is it all hype? Nat Clin Pract Gastroenterol Hepatol. 2007 May; 4(5):236-7.
33. Falize L, Guillygomarc'h A, Perrin M, Lainé F, Gyuader D, Brissot P, Turlin B, Deugnier Y. Reversibility of hepatic fibrosis in treated genetic hemochromatosis: a study of 36 cases. Hepatology 2006 Aug; 44(2):472-7.